Document is current
Any future updates will be listed below
-
Authors
Chen, Dandan http://orcid.org/0000-0003-1936-080X
Zigler, Christina K.
Lin, Li
Lucas, Nicole
McFatrich, Molly
Panagoulias, Jennifer
Berent, Allyson
Reeve, Bryce B.
-
Funding
Funding for this research was provided by:
Foundation for Angelman Syndrome Therapeutics (FT2018-005)
- License Information
-
More Information
Article History
Received: 30 November 2023
Accepted: 17 April 2024
First Online: 14 May 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The current study was ruled exempt from IRB review by the Duke University Health System. Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication sensitive nature of the research.
: Dr. Zigler, Dr. Reeve, Ms. Lucas, Ms. McFatrich, and Ms. Lin have developed the technology that is being used in the study. If the technology is commercially successful in the future, the developers and Duke University may benefit financially draft approval.
